ArticleOncotarget2015

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.

Elena Ciaglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.